Phosphodiesterase 4 inhibitors vs placebo
All‐cause mortality · patients with stable chronic obstructive pulmonary disease
Phosphodiesterase‐4 inhibitors showed no clear difference in mortality compared with placebo (moderate certainty).
1 finding from 1 review
- Phosphodiesterase‐4 inhibitors for chronic obstructive pulmonary disease 2020 · Cochrane Headline outcomes onlyOR 0.98 [0.77, 1.24]27 studies · 19786 participantsModerate